CRISPR Therapeutics
CRSP
#3114
Rank
$3.99 B
Marketcap
$46.85
Share price
3.22%
Change (1 day)
8.88%
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: $3.99 Billion USD

As of October 2024 CRISPR Therapeutics has a market cap of $3.99 Billion USD. This makes CRISPR Therapeutics the world's 3114th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024$3.99 B-19.76%
2023$4.97 B56.24%
2022$3.18 B-45.12%
2021$5.79 B-46.81%
2020$10.90 B194.5%
2019$3.70 B149.9%
2018$1.48 B56.74%
2017$0.94 B17.19%
2016$0.80 B

End of Day market cap according to different sources

On Oct 12th, 2024 the market cap of CRISPR Therapeutics was reported to be:

$3.99 Billion USD
by Yahoo Finance info icon info icon
$3.99 Billion USD
by CompaniesMarketCap info icon info icon
$3.99 Billion USD
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$0.65 B-83.51%๐Ÿ‡บ๐Ÿ‡ธ USA